Valsartan, Losartan and Irbesartan use in the USA, UK, Canada and Denmark after the nitrosamine recalls: a descriptive cohort study.

Eworuke E, Shinde M, Hou L, Paterson MJ, Jensen PB, Maro JC, Rai A, Scarnecchia D, Pennap D, Woronow D, Ghosh RE, Welburn S, Pottegard A, Platt RW, Lee H, Bradley MC

Open source

DOI: 10.1136/bmjopen-2022-070985
Published: 2023 Apr 17
Container: BMJ open
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1136/bmjopen-2022-070985,
  title = {Valsartan, Losartan and Irbesartan use in the USA, UK, Canada and Denmark after the nitrosamine recalls: a descriptive cohort study.},
  author = {Eworuke E and Shinde M and Hou L and Paterson MJ and Jensen PB and Maro JC and Rai A and Scarnecchia D and Pennap D and Woronow D and Ghosh RE and Welburn S and Pottegard A and Platt RW and Lee H and Bradley MC},
  year = {2023},
  journal = {BMJ open},
  doi = {10.1136/bmjopen-2022-070985},
  url = {https://doi.org/10.1136/bmjopen-2022-070985}
}

RIS

TY  - JOUR
TI  - Valsartan, Losartan and Irbesartan use in the USA, UK, Canada and Denmark after the nitrosamine recalls: a descriptive cohort study.
AU  - Eworuke E
AU  - Shinde M
AU  - Hou L
AU  - Paterson MJ
AU  - Jensen PB
AU  - Maro JC
AU  - Rai A
AU  - Scarnecchia D
AU  - Pennap D
AU  - Woronow D
AU  - Ghosh RE
AU  - Welburn S
AU  - Pottegard A
AU  - Platt RW
AU  - Lee H
AU  - Bradley MC
PY  - 2023
JO  - BMJ open
DO  - 10.1136/bmjopen-2022-070985
UR  - https://doi.org/10.1136/bmjopen-2022-070985
ER  -

APA

E, E., M, S., L, H., MJ, P., PB, J., JC, M., A, R., D, S., D, P., D, W., RE, G., S, W., A, P., RW, P., H, L., & MC, B. (2023). Valsartan, Losartan and Irbesartan use in the USA, UK, Canada and Denmark after the nitrosamine recalls: a descriptive cohort study.. BMJ open. https://doi.org/10.1136/bmjopen-2022-070985

Source records

pubmed · retrieved 2026-09-25T16:44:20.589Z